Scientists investigate why skin fails to heal in rare blistering disease
NCT ID NCT01874769
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how skin cells from 30 people with recessive dystrophic epidermolysis bullosa (RDEB) grow and repair wounds. RDEB is a rare genetic condition that causes fragile skin and painful blisters. Researchers took small skin samples to study the cells in a lab, aiming to better understand the disease. No new treatment was tested; the goal was to gather knowledge for future therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Guy's and ST Thomas NHS Foundation trust/Guy's Hospital
London, SE19RT, United Kingdom
-
Inserm U781 Service de Génétique Necker Hospital for sick children
Paris, 75743/ Cedex 15, France
-
Service de dermatologie Necker Hospital for sick children
Paris, 75743 Cedex 15, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gene therapy for 'Butterfly Skin' disease tracked for 15 years in major safety registry
- Anti-Inflammatory drug may ease swallowing in rare skin disease
- New hope for blistering skin diseases: drug targets antibodies to heal wounds
- Stanford launches study to better understand rare blistering skin disease
- Gene therapy gel aims to stop skin cancer from coming back in RDEB patients
- New cream could help kids with 'Butterfly Skin' heal faster